Revvity, Inc. (RVTY)
98.21
+1.94
(+2.02%)
USD |
NYSE |
Dec 17, 12:28
Revvity Research and Development Expense (Annual): 196.84M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Agilent Technologies, Inc. | 455.00M |
| Bruker Corp. | 376.50M |
| Avantor, Inc. | -- |
| Phibro Animal Health Corp. | 23.73M |
| Moderna, Inc. | 4.354B |